Home > Insider Trading > Filing (0001209191-21-055252)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1741830	Kronos Bio Inc.	KRON	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1826766	Christopher Dinsmore	C/O Kronos Bio, Inc. 1300 So. El Camino Real, Suite 300 San Mateo CA 94402	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-09-07	9,189	$3.27	105,549	No	4	M	Direct
Common Stock	Disposition	2021-09-07	9,189	$21.91	96,360	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2021-09-07	9,189	$0.00	9,189	$3.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
324,497		2030-06-14	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
The weighted average sale price for the transaction reported was $21.9068, and the range of prices were between $20.85 and $22.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Immediately exercisable.